Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].

Zhonghua wai ke za zhi [Chinese journal of surgery] - 1 May 2003

Dai Meng-hua, Zhao Yu-pei, Cai Li-xing, Zhu Yu

Abstract excerpt

OBJECTIVE: To confirm the effect of combined detection of K-ras gene mutation and CA 19-9 level in plasma in the diagnosis of pancreatic carcinoma. METHODS: In 33 patients without pancreatic carcinoma and 15 patients with pancreatic carcinoma, the value of K-ras mutation and CA 19-9 level were examined by enriched polymerase chain reaction (PCR) restriction fragment length polymorphism (RFLP) and radioimmunoassay...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Biomarkers, Tumor
Share to CA-19-9 Antigen

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genes, ras

Share to Mutation

Share to Pancreatic Neoplasms

Share to Polymorphism, Restriction Fragment Length

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 12892584

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Combined detection of K-ras mutation and CA 19-9 level in plasma of patients with pancreatic cancer].PMID 12892584Read ↗

[Significance of detection of K-ras gene mutations and CA19-9 in serum for diagnosis of pancreatic carcinoma].Semantic proximity Read ↗

[The diagnostic value of serum carcinoma markers, fecal K-ras and p53 gene mutation in pancreatic cancers].Semantic proximity Read ↗

Follow-up study of K-ras mutations in the plasma of patients with pancreatic cancer: correlation with clinical features and carbohydrate antigen 19-9.Semantic proximity Read ↗

[An application value of detecting K-ras and p53 gene mutation in the stool and pure pancreatic juice for diagnosis of early pancreatic cancer].Semantic proximity Read ↗

[Clinical usefulness of tumor markers associated with pancreatic cancer].Semantic proximity Read ↗

Prospective evaluation of the contribution of K-ras mutational analysis and CA 19.9 measurement to cytological diagnosis in patients with clinical suspicion of pancreatic cancer.Semantic proximity Read ↗

Values of mutations of K-ras oncogene at codon 12 in detection of pancreatic cancer: 15-year experience.Semantic proximity Read ↗

Quantity of mutant K-ras gene in pancreatic secretions for diagnosis of pancreatic carcinoma with different assays: analysis of 100 patients.Semantic proximity Read ↗

Detection of pancreatic carcinoma: diagnostic value of K-ras mutations in circulating DNA from serum.Semantic proximity Read ↗

Detecting K-ras and p53 gene mutation from stool and pancreatic juice for diagnosis of early pancreatic cancer.Semantic proximity Read ↗

Low correspondence between K-ras mutations in pancreatic cancer tissue and detection of K-ras mutations in circulating DNA.Semantic proximity Read ↗

New-onset type 2 diabetes mellitus--A high-risk group suitable for the screening of pancreatic cancer?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.